Mark your calendars now to experience the premiere global event focusing on improving health by championing scientific discovery and practice-changing educational content.
Begin your #AHA22 experience by submitting an abstract April 13 – June 9, 6:00 PM CST. We can’t wait to see you this November!
Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!
Members and attendees can now access informative, practice-changing sessions or earn CE credits for free -- through a different link. And nonmembers can purchase our Sessions package or our special CE bundle.
The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council members work to provide outstanding research, education, outreach, and mentorship opportunities.
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.
The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.
TAVR Low Risk Bicuspid Study | Basel Ramlawi, MD
Co-Principal Investigator Basel Ramlawi, MD summarizes the results of the TAVR Low Risk Bicuspid Study which he presented virtually for ACC 2020. The prospective single-arm interventional study examined TAVR for patients with severe aortic stenosis. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.